Context Therapeutics
Biotechnology Research · 2 Employees
Email Address: info@contexttherapeutics.com
- Overview
- Employees
Access 17 Verified Employees Profiles for Context TherapeuticsUnlock Free Contacts Now
About
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing medicines for solid tumors. Context is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, currently in preclinical development. Context is headquartered in Philadelphia. For more information, visit www.contexttherapeutics.com.
Year Founded
2015
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
2001 Market Street
Suite 3915, Unit 15
Philadelphia, Pennsylvania 19103, US
Keywords
Oncology and Bispecific Antibody
Location
- 2001 Market Street Suite 3915, Unit 15 Philadelphia, Pennsylvania 19103, US
Email Formats
Sign up for free credits and discover verified email addresses of Context Therapeutics
FormatExamples
first + last
andywarhol@contexttherapeutics.com
first_initial + last
awarhol@contexttherapeutics.com
first + last_initial
andyw@contexttherapeutics.com
first
andy@contexttherapeutics.com
last
warhol@contexttherapeutics.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Context Therapeutics and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.